Compare EPC & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EPC | DBVT |
|---|---|---|
| Founded | 1999 | 2002 |
| Country | United States | France |
| Employees | N/A | 90 |
| Industry | Package Goods/Cosmetics | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 918.9M | 948.8M |
| IPO Year | 1999 | 2014 |
| Metric | EPC | DBVT |
|---|---|---|
| Price | $27.74 | $14.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | $23.33 | ★ $32.04 |
| AVG Volume (30 Days) | ★ 576.3K | 337.2K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.76% | N/A |
| EPS Growth | N/A | ★ 10.26 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,223,500,000.00 | $5,636,000.00 |
| Revenue This Year | N/A | $35.04 |
| Revenue Next Year | $1.64 | $2,360.78 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 35.77 |
| 52 Week Low | $15.73 | $8.80 |
| 52 Week High | $29.95 | $26.19 |
| Indicator | EPC | DBVT |
|---|---|---|
| Relative Strength Index (RSI) | 50.10 | 48.46 |
| Support Level | $25.15 | $12.75 |
| Resistance Level | $28.01 | $14.68 |
| Average True Range (ATR) | 1.26 | 0.71 |
| MACD | -0.16 | 0.18 |
| Stochastic Oscillator | 24.52 | 63.94 |
Edgewell Personal Care Co is a personal-care company. The operating segments of the company include Wet Shave, Sun and Skin Care and Feminine Care. Wet Shave products include razor handles and refillable blades, disposable shave products, and shaving gels and creams. Sun and Skin Care consists of sun care products, men's and women's grooming products, Billie women's grooming products and personal wipe products. Feminine Care products include tampons, pads and liners. Some of the brands offered by the company include Edge, Skintimate, Personna, Schick, Carefree, Playtex, Banana Boat and Hawaiian Tropic. It derives a majority of its revenue from the United States.
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.